Technical and biological issues relevant to cell typing with aptamers

Journal of Proteome Research

Volumn 8, Issue 5, 2009, Pages 2438-2448

  Li, Na ^a   Ebright, Jessica N ^a   Stovall, Gwendolyn M ^a   Chen, Xi ^a   Nguyen, Hong Hanh ^a   Singh, Amrita ^a   Syrett, Angel ^a   Ellington, Andrew D ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Adherence; Aptamer; Array; Biomarker; Cancer; In vitro selection; SELEX

Indexed keywords

APTAMER; CELL SURFACE PROTEIN; ENZYME ANTIBODY; PROTEIN TYROSINE KINASE 7 ANTIBODY; PROTEOME; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL ADHESION; CELL LINE; CELL SURFACE; CELL TYPE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; WESTERN BLOTTING;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DNA, SINGLE-STRANDED; FLOW CYTOMETRY; HUMANS; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PROTEIN BINDING; PROTEOMICS; RECEPTOR PROTEIN-TYROSINE KINASES;

EUKARYOTA;

EID: 66749106259     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr801048z     Document Type: Article

References (46)

1. Kulasingam, V.; Diamandis, E. P. Tissue culture-based breast cancer biomarker discovery platform. Int. J. Cancer 2008, 123 (9), 2007-12.
2. Simpson, R. J.; Bernhard, O. K.; Greening, D. W.; Moritz, R. L. Proteomics-driven cancer biomarker discovery: looking to the future. Curr. Opin. Chem. Biol . 2008, 12 (1), 72-7.
3. Wingren, C.; Borrebaeck, C. A. Antibody microarrays: current status and key technological advances. Omics 2006, 10 (3), 411-27.
4. Borrebaeck, C. A.; Wingren, C. High-throughput proteomics using antibody microarrays: an update. Expert. Rev. Mol. Diagn . 2007, 7 (5), 673-86.
5. Chu, T.; Ebright, J.; Ellington, A. D. Using aptamers to identify and enter cells. Curr. Opin. Mol. Ther . 2007, 9 (2), 137-44.
6. Shangguan, D.; Li, Y.; Tang, Z.; Cao, Z. C.; Chen, H. W.; Mal- likaratchy, P.; Sefah, K.; Yang, C. J.; Tan, W. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc. Natl. Acad. Sci. U.S.A . 2006, 103 (32), 11838-43.
7. Syrett, H. A.; Collet, J. R.; Ellington, A. D. Aptamer Microarrays. In Functional Nucleic Acids for Analytical Applications; Lu, Y., Li, Y., Eds.; Integrated Analytical Systems; Springer: New York, 2009.
8. Huang, F.; Wang, G.; Coleman, T.; Li, N. Synthesis of adenosine derivatives as transcription initiators and preparation of 5' fluorescein- and biotin-labeled RNA through one-step in vitro transcription. Rna 2003, 9 (12), 1562-70.
9. Li, N.; Yu, C.; Huang, F. Novel cyanine-AMP conjugates for efficient 5' RNA fluorescent labeling by one-step transcription and replacement of [gamma-32P]ATP in RNA structural investigation. Nucleic Acids Res . 2005, 33 (4), e37.
10. Hamula, C. L.; Zhang, H.; Guan le, L.; Li, X. F.; Le, X. C. Selection of aptamers against live bacterial cells. Anal. Chem . 2008, 80 (20), 7812-9.
11. Berezovski, M. V.; Lechmann, M.; Musheev, M. U.; Mak, T. W.; Krylov, S. N. Aptamer-facilitated biomarker discovery (AptaBiD). J. Am. Chem. Soc . 2008, 130 (28), 9137-43.
12. Davis, K. A.; Abrams, B.; Lin, Y.; Jayasena, S. D. Use of a high affinity DNA ligand in flow cytometry. Nucleic Acids Res . 1996, 24 (4), 702-6.
13. Xiao, Z.; Shangguan, D.; Cao, Z.; Fang, X.; Tan, W. Cell-specific internalization study of an aptamer from whole cell selection. Chemistry 2008, 14 (6), 1769-75.
14. Cowperthwaite, M. C.; Ellington, A. D. Bioinformatic analysis of the contribution of primer sequences to aptamer structures. J. Mol. Evol . 2008, 67 (1), 95-102.
15. Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res . 2003, 31 (13), 3406-15.
16. Lupold, S. E.; Hicke, B. J.; Lin, Y.; Coffey, D. S. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res . 2002, 62 (14), 4029-33.
17. Chu, T. C.; Twu, K. Y.; Ellington, A. D.; Levy, M. Aptamer mediated siRNA delivery. Nucleic Acids Res . 2006, 34 (10), e73.
18. McNamara, J. O., 2nd.; Andrechek, E. R.; Wang, Y.; Viles, K. D.; Rempel, R. E.; Gilboa, E.; Sullenger, B. A.; Giangrande, P. H. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol . 2006, 24 (8), 1005-15.
19. Wullner, U.; Neef, I.; Eller, A.; Kleines, M.; Tur, M. K.; Barth, S. Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2. Curr. Cancer. Drug. Targets 2008, 8 (7), 554-65.
20. Ferreira, C. S.; Matthews, C. S.; Missailidis, S. DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers. Tumour Biol . 2006, 27 (6), 289-301.
21. Hicke, B. J.; Marion, C.; Chang, Y. F.; Gould, T.; Lynott, C. K.; Parma, D.; Schmidt, P. G.; Warren, S. Tenascin-C aptamers are generated using tumor cells and purified protein. J. Biol. Chem . 2001, 276 (52), 48644-54.
22. Chen, C. H.; Chernis, G. A.; Hoang, V. Q.; Landgraf, R. Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3. Proc. Natl. Acad. Sci. U.S.A . 2003, 100 (16), 9226-31.
23. Mallikaratchy, P.; Tang, Z.; Kwame, S.; Meng, L.; Shangguan, D.; Tan, W. Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol. Cell. Proteomics 2007, 6 (12), 2230-8.
24. Berkers, J. A.; van Bergen en Henegouwen, P. M.; Boonstra, J. Three classes of epidermal growth factor receptors on HeLa cells. J. Biol. Chem . 1991, 266 (2), 922-7.
25. Chang, H.; Benchimol, S.; Minden, M. D.; Messner, H. A. Alterations of p53 and c-myc in the clonal evolution of malignant lymphoma. Blood 1994, 83 (2), 452-9.
26. Tan, D.; Deeb, G.; Wang, J.; Slocum, H. K.; Winston, J.; Wiseman, S.; Beck, A.; Sait, S.; Anderson, T.; Nwogu, C.; Ramnath, N.; Loewen, G. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization. Diagn. Mol. Pathol . 2003, 12 (4), 201-11.
27. Shangguan, D.; Cao, Z. C.; Li, Y.; Tan, W. Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples. Clin. Chem . 2007, 53 (6), 1153-5.
28. Shangguan, D.; Cao, Z.; Meng, L.; Mallikaratchy, P.; Sefah, K.; Wang, H.; Li, Y.; Tan, W. Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J. Proteome Res . 2008, 7 (5), 2133-9.
29. Tang, Z.; Shangguan, D.; Wang, K.; Shi, H.; Sefah, K.; Mallikratchy, P.; Chen, H. W.; Li, Y.; Tan, W. Selection of aptamers for molecular recognition and characterization of cancer cells. Anal. Chem . 2007, 79 (13), 4900-7.
30. Davis, K.; Lin, Y.; Abrams, B.; Jayasena, S. D. Staining of cell surface human CD4 with 2'-F-pyrimidine-containing RNA aptamers for flow cytometry. Nucleic Acids Res . 1998, 26 (17), 3915-24.
31. Park, E.; Baron, R.; Landgraf, R. Higher-order association states of cellular ERBB3 probed with photo-cross-linkable aptamers. Biochemistry 2008, 47 (46), 11992-2005.
32. Raddatz, M. L.; Dolf, A.; Endl, E.; Knolle, P.; Famulok, M.; Mayer, G. Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. Angew. Chem., Int. Ed . 2008, 47 , 5190-3.
33. Chang, S. S.; Reuter, V. E.; Heston, W. D.; Bander, N. H.; Grauer, L. S.; Gaudin, P. B. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor- associated neovasculature. Cancer Res . 1999, 59 (13), 3192-8.
34. Shin, W. S.; Maeng, Y. S.; Jung, J. W.; Min, J. K.; Kwon, Y. G.; Lee, S. T. Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis. Biochem. Biophys. Res. Commun . 2008, 371 (4), 793-8.
35. Lu, X.; Borchers, A. G.; Jolicoeur, C.; Rayburn, H.; Baker, J. C.; Tessier-Lavigne, M. PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature (London) 2004, 430 (6995), 93-8.
36. Pulido, D.; Campuzano, S.; Koda, T.; Modolell, J.; Barbacid, M. Dtrk, a drosophila gene related to the trk family of neurtrophin receptors, encodes a novel class of neural cell adhesion molecule. EMBO J . 1992, 11, 391-404.
37. Jung, J. W.; Ji, A. R.; Lee, J.; Kim, U. J.; Lee, S. T. Organization of the human PTK7 gene encoding a receptor protein tyrosine kinase- like molecule and alternative splicing of its mRNA. Biochim. Biophys. Acta 2002, 1579 (2-3), 153-63.
38. Kremmidiotis, G.; Baker, E.; Crawford, J.; Eyre, H. J.; Nahmias, J.; Callen, D. F. Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity. Genomics 1998, 49 (3), 467-71.
39. Corn, P. G.; Smith, B. D.; Ruckdeschel, E. S.; Douglas, D.; Baylin, S. B.; Herman, J. G. E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia. Clin. Cancer Res . 2000, 6 (11), 4243-8.
40. Shimamoto, T.; Ohyashiki, J. H.; Ohyashiki, K. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia. Leuk. Res . 2005, 29 (6), 653-9.
41. Takubo, T.; Kanashima, H.; Terada, Y.; Aoyama, Y.; Nakamae, H.; Yamamura, R.; Shima, E.; Makita, K.; Tanaka, K.; Ohta, K.; Yamane, T.; Hino, M.; Kamitani, T.; Tatsumi, N. Clinical significance of serum E-cadherin levels in patients with haematological malignancies. Haematalogia (Budap) 2002, 31 (4), 319-25.
42. Loeffler-Ragg, J.; Steurer, M.; Ulmer, H.; Skvortsov, S.; Kircher, B.; Herold, M.; Zwierzina, H.; Stauder, R. Elevated levels of serum CD44 and E-cadherin predict an unfavourable outcome in my- elodysplastic syndromes. Leukemia 2006, 20 (11), 2064-7.
43. Shin, W.; Maeng, Y.; Jung, J.; Min, J.; Kwon, Y.; Lee, S. Soluble PTK7 inhitbits tube formation, migration and invasion of endothelial cells and angiogenesis. Biochem. Biophys. Res. Commun . 2008, 371 , 793-8.
44. Ruidavets, J.; Cariven, P.; Demur, C.; Payrastre, B.; Laurent, G.; Racaud-Sultan, C. Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. Cancer Res . 2004, 64 , 3191-7.
45. Pasternak, G.; Hochhaus, Schultheis, B.; Hehlmann, R. Chronic myelogenous leukemia: molecular and cellular aspects. J. Cancer Res. Clin. Oncol . 1998, 124, 643-60.
46. Smith, J. E.; Medley, C. D.; Tang, Z.; Shangguan, C. L.; Tan, W. Aptamer-Conjugated Nanoparticles for the Collection and Detection of Multiple Cancer Cells. Anal. Chem . 2007, 79 (8), 3075-82.